• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Egyptian Journal of Plastic and Reconstructive Surgery
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 49 (2025)
Volume Volume 48 (2024)
Volume Volume 47 (2023)
Volume Volume 46 (2022)
Volume Volume 45 (2021)
Volume Volume 44 (2020)
Volume Volume 43 (2019)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 42 (2018)
Zidan, A., Azzam, E., Elwakeel, H. (2020). Assessment of Microneedling Devices as Transepidermal Drug Delivering System for Corticosteroid in Treatment of Hypertrophic Scars. The Egyptian Journal of Plastic and Reconstructive Surgery, 43(3), 533-537. doi: 10.21608/ejprs.2020.68214
Ahmed A Zidan; Ehab Z Azzam; Helmy Elwakeel. "Assessment of Microneedling Devices as Transepidermal Drug Delivering System for Corticosteroid in Treatment of Hypertrophic Scars". The Egyptian Journal of Plastic and Reconstructive Surgery, 43, 3, 2020, 533-537. doi: 10.21608/ejprs.2020.68214
Zidan, A., Azzam, E., Elwakeel, H. (2020). 'Assessment of Microneedling Devices as Transepidermal Drug Delivering System for Corticosteroid in Treatment of Hypertrophic Scars', The Egyptian Journal of Plastic and Reconstructive Surgery, 43(3), pp. 533-537. doi: 10.21608/ejprs.2020.68214
Zidan, A., Azzam, E., Elwakeel, H. Assessment of Microneedling Devices as Transepidermal Drug Delivering System for Corticosteroid in Treatment of Hypertrophic Scars. The Egyptian Journal of Plastic and Reconstructive Surgery, 2020; 43(3): 533-537. doi: 10.21608/ejprs.2020.68214

Assessment of Microneedling Devices as Transepidermal Drug Delivering System for Corticosteroid in Treatment of Hypertrophic Scars

Article 28, Volume 43, Issue 3, October 2020, Page 533-537  XML PDF (7.91 MB)
Document Type: Original Article
DOI: 10.21608/ejprs.2020.68214
View on SCiNiTO View on SCiNiTO
Authors
Ahmed A Zidan* ; Ehab Z Azzam; Helmy Elwakeel
The Department of General Surgery, Plastic Surgery Unit, Faculty of Medicine, Alexandria University, Egypt
Abstract
Background: Hypertrophic scars are one of dermal fibroproliferative
disorders which can lead to pruritus, disfigurement
and pain. The use of microneedling to introduce topical agents
or drugs into the dermis is a rapidly growing and popular
skin/scar treatment.
Patients and Methods: This is a prospective randomized
study that included 30 patients suffering from Hypertrophic
scars and they are candidate for the proposed technique.
Microneedling by Dermapen device with application of topical
triamcinolone acetonide solution on scar tissue for three
sessions with 3 weeks interval in between.
Results: During one year, 30 patients were recruited in
our study, the mean age of the patients was 28.16±11.24 (range
21-58 year) and 52% of patients were female. Lesions location
were anterior chest (8), extremities (18) and back (4). Mean
zero VSS scores were achieved with triamcinolone transepidermal
injection in respect of scar height (week 15th) and
pliability (week 15th).
Conclusion: Our results did support the capability of
triamcinolone transepidermal injection using Dermapen in
treatment of hypertrophic scars, with an efficient, less painful
and cost-effective procedure.
Keywords
Microneedling devices – Transepidermal – Corticosteroids; – Hypertrophic scar
Main Subjects
New technologies and products
References
1- Bock O., Schmid-Ott G., Malewski P. and Mrowietz U.:
Quality of life of patients with keloid and hypertrophic
scarring. Arch. Dermatol. Res., 297 (10): 435, 2006.
2- O'Sullivan S.T., O'Shaughnessy M. and O'Connor T.P.:
Aetiology and management of hypertrophic scars and
keloids. Ann. R. Coll. Surg. Engl., 78 (3 Pt 1): 168, 1996.
3- Al-Attar A., Mess S., Thomassen J.M., Kauffman C.L.
and Davison S.P.: Keloid pathogenesis and treatment.
Plast. Reconstr. Surg., 117 (1): 286-300, 2006.
Table (1): Mean VSS scores during therapy and follow-up.
VSS Time
parameter
Height
Pliability
Vascularity
Pigmentation
VSS
Week 0
2.63±0.41
3.90±0.78
2.44±0.50
2.74±0.37
11.98±1.36
Week 3
1.96±0.49
2.88±0.65
2.22±0.54
2.62±0.45
9.66±1.29
Week 6
1.18±0.62
1.88±0.79
1.7±0.54
2.40±0.49
7.18±1.75
Week 9
0.6±0.57
0.94±0.76
1.36±0.45
2.32±0.50
5.18±1.75
Month 3
0.22±0.50
0.32±0.62
1.22±0.41
2.28±0.49
4.06±1.27
p-value
<0.001
<0.001
<0.001
<0.001
<0.001
Table (2): Symptoms change in the studied cases.
Symptoms change
Improvement
Unchanged
10
3
Number of patients
Egypt, J. Plast. Reconstr. Surg., October 2019 537
4- Gauglitz G.G.: Management of keloids and hypertrophic
scars: Current and emerging options. Clin. Cosmet. Investig.
Dermatol., 6: 103, 2013.
5- Tanzi E.L. and Aister T.S.: Laser treatment of scarsadvances
in dermatologic surgery. Skin. Ther. Lett., 9 (1):
4-7, 2004.
6- Robertson J.C., Hodgson B., Druett J.E. and Druett J.:
Pressure therapy for hypertrophic scarring: Preliminary
communication. J. R. Soc. Med., 73 (5): 348-54, 1980.
7- Hatamipour E., Mehrabi S., Hatamipour M. and Shirazi
H.R.: Effects of combined intralesional 5-fluorouracil and
topical silicone in prevention of keloids: A double blind
randomized clinical trial study. Acta Med. Iran, 49 (3):
127, 2011.
8- Chrousos G.P. and Margioris A.N.: Adrenocorticosteroid
& cortico-adrenal antagonists in Katzung BG. Basic and
clinical pharmacology. 8th ed. The McGraw-Hill: United
States of America, 574-89, 2003.
9- Garg G.A., Sao P.P. and Khopkar U.S.: Effect of carbon
dioxide laser ablation followed by intralesional steroids
on keloids. J. Cutan. Aesthet. Surg., 4 (1): 2-6, 2011.
10- Elsaie M.L., Baumann L.S. and Elsaie L.T.: Striae distensae
(stretch marks) and different modalities of therapy: An
update. Dermatol. Surg., 35 (4): 563-73, 2009.
11- Gómez C., Costela A., García-Moreno I., Llanes F., Teijón
J.M. and Blanco D.: Laser treatment on skin enhancing
and controlling transdermal delivery of 5-fluorouracil.
Laser Surg. Med., 40 (1): 6-12, 2008.
12- Donelly R.F., Morrow D.I., McCarron P.A., Woolfson
A.D., Morrissey A., Juzenas P., Juzeniene A., Iani V.,
McCarthy H.O. and Moan J.: Microneedle-mediated
intradermal delivery of 5-aminolevulinic acid: Potential
for enhanced topical photodynamic therapy. J. Control
Release, 129 (3): 154-62, 2008.
13- Issa M.C.A., Kassuga L.E.B.P., Chevrand N.S. and Pires
M.T.F.: Topical delivery of triamcinolone via skin pretreated
with ablative radiofrequency: A new method in
hypertrophic scar treatment. Int. J. Dermatol., 52: 367-
70, 2012.
14- Wolfram D., Tzankov A., Pülzl P. and Piza-Katzer H.:
Hypertrophic scars and keloids-a review of their pathophysiology,
risk factors, and therapeutic management.
Transepidermal Drug Delivery: Overview, Concept and
Applications. Dermatol. Surg., 35 (2): 171-81, 2009.
15- Schwarz M. and Laaff H.A.: Prospective controlled
assessment of microneedling with the Dermaroller device.
Plast. Reconstr. Surg., 127 (6): 146e-148e, 2011.
16- Niwat P.: Percutaneous collagen induction with dermaroller
for management of atrophic acne scars in 31 Thai patients.
J. Cosmet. Dermatol., 2 (1): 1-13, 2009.
17- Baryza M.J. and Baryza G.A.: The Vancouver Scar Scale:
An administration tool and its interrater reliability. J.
Burn Care Res., 16: 535-8, 1995.
18- Haerdersdal M., Sakamoto F.H., Farinelli W.A., Doukas
A.G., Tam J. and Anderson R.R.: Fractional CO(2) laserassisted
drug delivery. Laser Surg. Med., 42 (2): 113-
22, 2010.
19- Stumpp O.F., Welch A.J., Milner T.E. and Neev J.: Enhancement
of transepidermal skin clearing agent delivery
using a 980nm diode laser. Lasers Surg. Med., 37 (4):
278-85, 2005.
20- Wang K.F., Fang J.Y., Hu C.H. and Lee W.R.: Erbium:
YAG laser pretreatment accelerates the response of Bowen's
disease treated by topical 5-fluorouracil. Dermatol.
Surg., 30 (3): 441-5, 2004.
21- Sharad J.: Combination of microneedling and glycolic
acid peels for the treatment of acne scars in dark skin. J.
Cosmet. Dermatol., 10 (4): 317-23, 2011.
22- Orentreich D.S. and Orentreich N.: Subcutaneous incisionless
(subcision) surgery for the correction of depressed
scars and wrinkles. Dermatol. Surg., 21 (6): 543-9, 1995.
23- Aust M.C., Reimers K., Repenning C., Stahl F., Jahn S.,
Guggenheim M., Schwaiger N., Gohritz A. and Vogt P.M.:
Percutaneous collagen induction: Minimally invasive skin
rejuvenation without risk of hyperpigmentation-fact or
fiction? Plast. Reconstr. Surg., 122 (5): 1553-63, 2008.
24- Patnaik V.V.G., Singla R. and Bala S.: Anatomy of 'a
beautiful face & smile'. J. Anat. Soc. India, 52 (1): 74-80
16. Sharad J. (2011) Combination of microneedling and
glycolic acid peels for the treatment of acne scars in dark
skin. J. Cosmet. Dermatol., 10 (4): 317-23, 2003

Statistics
Article View: 436
PDF Download: 1,570
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.